News
Konczak lab receives NIH grant to study new treatment for chronic cough
The Human Sensorimotor Control Lab (HSC Lab) received a second phase of funding from the National Institutes of Health for a clinical trial for people with chronic cough.
In collaboration with colleagues in the Department of Otolaryngology, the Human Sensorimotor Control Lab (HSC Lab) received the second phase of funding of a $494,136 award from the National Institutes of Health (NIH). The funded project examines laryngeal vibration as a possible treatment for people with unexplained chronic cough, a condition that affects an estimated 5% of all Americans. Because the pathophysiology of chronic cough is not well understood, these patients have very limited treatment options. Our earlier proof-of-concept work could document that a subgroup of people with chronic cough respond to laryngeal vibration and this award seeks to substantiate this finding in a clinical trial. Jürgen Konczak, PhD, professor in the School of Kinesiology and director of the HSC Lab, serves as Co-PI; Dr. Stephanie Misono from Otolaryngology, who sees patients in her clinic, is the PI of the grant.